PTPRG and chronic myelogenous leukemia, BCR-ABL1 positive: We performed a retrospective analysis of a group of 39 CML patients (described in Additional file 1: Table S2) evaluated at diagnosis and after the indicated treatment by measuring PTPRG messenger RNA (mRNA) levels by RQ-PCR.